Discounted Cash Flow
Nutex Health Inc.
—
—
Average annual growth rates
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Endpoint CAGR (better for long term trend)
| Metric | 10-Year | 5-Year | 3-Year |
|---|---|---|---|
| Sales | — | — | — |
| Free Cash Flow | — | — | — |
| Average (FCF & NI) | — | — | — |
| Net Income | — | — | — |
Projected growth rate
—
—
%
%
Historical inputs (10 fiscal years)
| YEAR | Sales | Net Income | Free Cash Flow | Net Margin | EPS (diluted) |
|---|---|---|---|---|---|
| 2016 | $0 | $-7.4m | $-274.2k | — | $-0.19 |
| 2017 | $23.2k | $582.1k (107.8%) | $-714.6k (-160.6%) | 2512.6% | $0.01 (105.3%) |
| 2018 | $60.2k (160.0%) | $-2.8m (-583.5%) | $-765.5k (-7.1%) | -4673.0% (-286.0%) | $-0.56 (-5700.0%) |
| 2019 | $1.4m (2168.9%) | $-7.1m (-152.9%) | $-4.1m (-438.8%) | -520.8% (88.9%) | $-1.96 (-250.0%) |
| 2020 | $1.6m (16.1%) | $-5.7m (20.6%) | $-1.5m (64.2%) | -356.3% (31.6%) | $0.18 (109.2%) |
| 2021 | $18.8m (1085.0%) | $-13.7m (-141.9%) | $-43.6m (-2857.8%) | -72.7% (79.6%) | $0.22 (22.2%) |
| 2022 | $219.3m (1066.8%) | $-424.8m (-3007.7%) | $36.0m (182.5%) | -193.7% (-166.3%) | $-0.67 (-404.5%) |
| 2023 | $247.6m (12.9%) | $-45.8m (89.2%) | $-8.2m (-122.9%) | -18.5% (90.5%) | $-0.07 (89.6%) |
| 2024 | $479.9m (93.8%) | $52.1m (213.8%) | $20.8m (353.0%) | 10.9% (158.7%) | $10.23 (14714.3%) |
| 2025 | $875.3m (82.4%) | $70.8m (35.9%) | $245.6m (1078.0%) | 8.1% (-25.5%) | $11.13 (8.8%) |
Base FCF: — (latest fiscal year)
Discount rate: % —
Terminal growth: —
Projection period: — years
Alt A decline yrs:
Alt B total yrs:
Projected cash flows
| Year | Projected cash flow | Discount Factor | Present Value |
|---|
PV of projected FCF: —
Terminal FCF: —
Terminal value: —
PV of terminal value: —
Enterprise value (DCF): —
Current price: —
—Alternative DCF Models
| Model | Fair Value | Upside | PV(FCFs) | PV(Terminal) | Total Years |
|---|---|---|---|---|---|
| Standard (10yr→TV) | — | — | — | — | 10 + TV |
| Alt A (Gradual Decline) | — | — | — | — | — |
| Alt B (30yr Hard Stop) | — | — | — | N/A | — |
This is a simplified DCF model for illustration. It uses reported free cash flow, a single growth assumption, fixed WACC, and a Gordon Growth terminal value. It is not investment advice.